Prenatal lead exposure enhances methamphetamine sensitization in rats

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 2, 2009, Pages 165-169

  Clifford, P Shane ^a   Hart, Nigel ^a   Thompson, Jeff ^a,b   Buckman, Sam ^a,b   Wellman, Paul J ^a   Bratton, Gerald R ^b   Nation, Jack R ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Lead; Methamphetamine; Sensitization

Indexed keywords

ACETIC ACID; LEAD ACETATE; METHAMPHETAMINE; SODIUM CHLORIDE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREEDING; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FEEDING; FEMALE; FLUID INTAKE; FOOD INTAKE; GESTATION PERIOD; LACTATION; LOCOMOTION; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; RAT; SENSITIZATION; WEANING;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LEAD; LEAD POISONING, NERVOUS SYSTEM; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; STEREOTYPED BEHAVIOR;

ANIMALIA; RATTUS;

EID: 67649265149     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.05.001     Document Type: Article

References (40)

1. Anglin M.D., Burke C., Perrochet B., Stamper E., and Dawud-Noursi S. History of the methamphetamine problem. J Psychoact Drugs 32 (2000) 137-141
2. Bellinger D.C. Neurobehavioral assessment in studies of exposure to neurotoxicants. Neurotoxicity and developmental disabilities. Int Rev Res Ment Retard 30 (2006) 263-300
3. Canfield R.L., Henderson Jr. C.R., Cory-Slechta D.A., Cox C., Jusko T.A., and Lanphear B.P. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. New Engl J Med 348 (2003) 1517-1526
4. Cho A.K., and Melega W.P. Patterns of methamphetamine abuse and their consequences. J Addict Dis 21 1 (2002) 21-34
5. Cory-Slechta D.A. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Ann Rev Pharmacol Toxicol 35 (1995) 391-415
6. Cory-Slechta D.A. Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity. Neurotoxicology 18 3 (1997) 673-688
7. Crèvecoeur D., Rutkowski B., and Rawson R.A. The rise in treatment admissions for methamphetamine use in Los Angeles County from 2001 through 2005. J Psychoact Drugs Suppl 4 (2007) 383-392 (Nov)
8. Devoto P., Flore G., Ibba A., Fratta W., and Pani L. Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis. Toxicol Lett 121 (2001) 199-206
9. Ensminger M.E., Anthony J.C., and McCord J. The inner city and drug use: initial findings from an epidemiological study. Drug Alcohol Depend 48 3 (1997) 175-184 (Dec 15)
10. Hall D.A., Stanis J.J., Avila H.M., and Gulley J.M. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior. Psychopharmacology 195 (2008) 469-478
11. Holson R.R., and Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 14 (1992) 221-228
12. Howell L.L., and Kimmel H.L. Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75 (2008) 196-217
13. Hubbs-Tait L., Nation J.R., Krebs N., and Bellinger D.C. Neurotoxicants, micronutrients, and social environments: individual and combined effects on children's development. Psychol Sci Pub Interest 5 (2005) 57-121
14. Iritani B.J., Hallfors D.D., and Bauer D.J. Crystal methamphetamine use among young adults in the USA. Addiction 102 7 (2007) 1102-1113
15. Kemp F.W., Neti P.V., Howell R.W., Wenger P., Louria D.B., and Bogden J.D. Elevated blood lead concentrations and vitamin D deficiency in winter and summer in young urban children. Environ Health Perspect 15 (2007) 630-635
16. Lamphear B.P., Hornung R., Khoury J., Yolton K., Baghurst P., Bellinger D.C., et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 113 (2005) 894-899
17. Lasley S.M., and Gilbert M.E. Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead. Brain Res 736 1-2 (1996) 125-134 (Oct 14)
18. Lin Z., and Uhl G.R. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism. Mol Pharmacol 61 (2002) 885-891
19. Mielke H.W. Lead in the inner cities. Am Sci 87 (1999) 62-73
20. Mielke H.W., Gonzales C., Powell E., and Mielke Jr. P.W. Urban soil-lead (Pb) footprint: retrospective comparison of public and private properties in New Orleans. Environ Geochem Health 30 3 (2008) 231-242 (Jun)
21. Nation J.R., Cardon A.L., Heard H.M., Valles R., and Bratton G.R. Perinatal lead exposure and relapse to drug-seeking behavior in the rat: a cocaine reinstatement study. Psychopharmacology 168 (2003) 236-243
22. Nation J.R., Livermore C.L., and Burkey R.T. Chronic lead exposure attenuates sensitization to the locomotor-stimulating effects of cocaine. Drug Alcohol Depend 41 (1996) 143-149
23. Nation J.R., Miller D.K., and Bratton G.R. Developmental lead exposure alters the stimulatory properties of cocaine at PND 30 and PND 90 in the rat. Neuropsychopharmacology 24 (2000) 444-454
24. Nation J.R., Smith K.R., and Bratton G.R. Early developmental lead exposure increases sensitivity to cocaine in a self-administration paradigm. Pharmacol Biochem Behav 77 (2004) 127-135
25. Pirkle J.L., Kaufmann R.B., Brody D.J., Hickman T., Gunter E.W., and Paschal D.C. Exposure of the U.S. population to lead, 1991-1994. Environ Health Perspect 11 (1998) 745-750
26. Pokora M.J., Richfield E.K., and Cory-Slechta D.A. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. J Neurochem 67 4 (1996) 1540-1550 (Oct)
27. Post R.M., Lockfeld A., Squillace K.M., and Contel N.R. Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci 28 (1981) 755-760
28. Rawson R.A., and Condon T.P. Why do we need an addiction supplement focused on methamphetamine?. Addiction 102 (2007) 1-4
29. Rivière G.J., Byrnes K.A., Gentry W.B., and Owens S.M. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 291 3 (1999) 1220-1226 (Dec)
30. Rocha A., Valles R., Bratton G.R., and Nation J.R. Developmental lead exposure alters methamphetamine self-administration in the male rat: acquisition and reinstatement. Drug Alcohol Depend 95 (2008) 23-29
31. Rocha A., Valles R., Cardon A.L., Bratton G.R., and Nation J.R. Self-administration of heroin in rats: effects of low-level lead exposure during gestation and lactation. Psychopharmacology 174 (2004) 203-210
32. Rocha A., Valles R., Cardon A.L., Bratton G.R., and Nation J.R. Enhanced acquisition of cocaine self-administration in rats developmentally exposed to lead. Neuropsychopharmacology 30 (2005) 2058-2064
33. Rocha A., Valles R., Hart N., Bratton G.R., and Nation J.R. Developmental lead exposure attenuates methamphetamine dose-effect self-administration performance and progressive ratio responding in the male rat. Pharmacol Biochem Behav 89 (2008) 508-514
34. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 479 (2001) 23
35. Sandberg P.R., Zoloty S.A., Willis R., Ticarich C.D., Rhoads K., Nagy R.P., et al. Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats. Pharmacol Biochem Behav 27 (1987) 569-572
36. Segal D.S., and Kuczenski R. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance. Neuropsychopharmacology 31 (2006) 941-955
37. A antagonist bicuculline on cocaine self-administration in rats exposed to lead during gestation/lactation. Pharmacol Biochem Behav 80 (2005) 611-619
38. Wellman P.J., Davis K.W., Clifford P.S., Rothman R.B., and Blough B.E. Changes in feeding and locomotion induced by amphetamine analogs in rats. Drug Alcohol Depend 100 3 (2009) 234-239 (Mar 1)
39. White L.D., Cory-Slechta D.A., Gilbert M.E., Tiffany-Castiglioni E., Zawia N.H., Virgolini M., et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 225 1 (2007 Nov15) 1-27
40. Zuch C.L., O Mara D.J., and Cory-Slechta D.A. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment. Toxicol Appl Pharmacol 150 1 (1998) 174-185